Dr. Xiaoyu Li received his B.S. degree from Peking University in 1997 and Ph.D. degree in Chemistry in 2002 from the University of Chicago in the research group of Prof. David G. Lynn. His Ph.D. research focused on nucleic acid chemistry and organic synthesis. After a postdoctoral training at Harvard University under the guidance of Prof. David R. Liu on DNA-templated synthesis in 2002-2004, he took a Senior Scientist position at Ensemble Discovery conducting research on anti-cancer and anti-inflammation drugs. In 2007, he joined the Chemical Biology Platform at the Broad Institute of MIT and Harvard as a Research Scientist, primarily working on target identification of bioactive small molecules and diversity-oriented synthesis. In Nov. 2009, he returned to China and started his independent career as an Associate Professor at College of Chemistry and Molecular Engineering, Peking University, where he became tenured Associate Professor in 2015. In Oct. 2015, Dr. Li joined Department Chemistry, The University of Hong Kong as an Associate Professor. Dr. Li’s research interests lie in the field of Chemical Biology with focuses on DNA-encoded chemical library (DEL), protein labeling and profiling, and target identification of bioactive small molecules. His group has made major contributions to the development of DEL technology and its applications. His work has been applied in a number of drug discovery programs in pharmaceutical companies. Dr. Li is a Beijing Nova Program awardee and a recipient of the Greenleaf Distinguished Young Investigator in Biomedical Research. In 2014-2016, he has been selected as one of the “Most Cited Chinese Researchers (biochemistry, genetics, and molecular biology)” by Elsevier.